Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyell Immunopharma (LYEL) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to $8.6 million.

  • Lyell Immunopharma's Prepaid Assets fell 969.68% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 969.68%. This contributed to the annual value of $9.1 million for FY2024, which is 713.69% up from last year.
  • As of Q3 2025, Lyell Immunopharma's Prepaid Assets stood at $8.6 million, which was down 969.68% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Lyell Immunopharma's Prepaid Assets ranged from a high of $12.2 million in Q3 2021 and a low of $5.4 million during Q2 2025
  • For the 5-year period, Lyell Immunopharma's Prepaid Assets averaged around $10.0 million, with its median value being $10.5 million (2021).
  • As far as peak fluctuations go, Lyell Immunopharma's Prepaid Assets skyrocketed by 13319.81% in 2021, and later tumbled by 3769.1% in 2025.
  • Over the past 5 years, Lyell Immunopharma's Prepaid Assets (Quarter) stood at $11.5 million in 2021, then decreased by 3.04% to $11.1 million in 2022, then dropped by 24.05% to $8.5 million in 2023, then rose by 7.14% to $9.1 million in 2024, then fell by 5.4% to $8.6 million in 2025.
  • Its Prepaid Assets was $8.6 million in Q3 2025, compared to $5.4 million in Q2 2025 and $8.0 million in Q1 2025.